David Lucchino

David Lucchino

Directeur/Membre du Conseil chez
The Multiple Myeloma Research Foundation, Inc.
58 ans
Health Technology
Commercial Services
Consumer Services

Profil

David L.
Lucchino
was the founder of Semprus BioSciences Corp., serving as President, Chief Executive Officer & Director from 2005 to 2012.
Mr. Lucchino was the founder of Frequency Therapeutics, Inc., serving as President, CEO, Secretary & Director from 2014 to 2023.
Mr. Lucchino is also the founder of Lauchcyte.
Mr. Lucchino is currently President & Chief Executive Officer at Brenig Therapeutics, Inc. since 2025, Director at The Multiple Myeloma Research Foundation, Inc., Director at National Outdoor Leadership School, and Member-College of Fellows at American Institute For Medical & Biological Engineering.
Former positions include President & Chief Executive Officer at Entrega, Inc. from 2014 to 2016, Chairman at Massachusetts Biotechnology Council, Director at Lipella Pharmaceuticals, Inc., Director at Advanced Medical Technology Association, Independent Director at Korro Bio, Inc. from 2023 to 2024, Senior Associate at Polaris Growth Management LLC from 2005 to 2007, and Trustee at Mount Auburn Hospital from 2007 to 2021.
Education includes an undergraduate degree from Denison University in 1991, an MBA from MIT Sloan School of Management in 2006, and a graduate degree from S.I.
Newhouse School of Public Communications in 1997.

Postes actifs de David Lucchino

SociétésPosteDébut
Directeur/Membre du Conseil -
Corporate Officer/Principal -
Directeur/Membre du Conseil -

Anciens postes connus de David Lucchino

SociétésPosteFin
Directeur Général 30/10/2025
KORRO BIO, INC. Fondateur 01/11/2023
Directeur/Membre du Conseil 01/01/2021
Directeur Général 01/06/2016
Voir l'expérience en détail de David Lucchino

Formation de David Lucchino

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

78

Relations au 1er degré

16

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées16

Health Technology

Health Technology

Finance

Consumer Services

Commercial Services

Health Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Lauchcyte

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Lucchino
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT